Cost Analysis of Thromboprophylaxis in Patients at High Thromboembolic Risk with Enoxaparin, Dalteparin and Nadroparin in Colombia: A Systematic Literature Review-Based Study
Enoxaparin is the least expensive health technology for thromboprophylaxis in most of the medical contexts analyzed in Colombia due to its efficacy and the lower risk of complications than dalteparin and nadroparin.
Authors
- Josefina Zakzuk (ORCID: https://orcid.org/0000-0002-6007-5376)
- José Rojas‐Suarez (ORCID: https://orcid.org/0000-0003-0310-3235)
- Julio Clavijo
- S. Gutiérrez (ORCID: https://orcid.org/0009-0006-3218-0044)
- Liliana Silva Gomez
- Nelson J Alvis-Zakzuk (ORCID: https://orcid.org/0000-0001-9382-214X)
- Juan-Felipe López (ORCID: https://orcid.org/0000-0002-9993-9530)
Institutions
- University of Cartagena (CO)
- University of the Coast (CO)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ceor.s472192
- Citations
- 1
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- Sanofi